肺有效动脉弹性对心力衰竭患者预后的预测价值
该回顾性队列研究纳入284例心衰患者,以右心导管计算肺有效动脉弹性(Ea),按中位值0.555 mmHg/ml分组。Ea升高与右心室后负荷指标相关,是心衰患者不良预后的独立预测因子,AUC为0.724。
要点
- Ea升高是心衰患者主要临床事件的独立预测因子(HR=1.734)。
- Ea与肺动脉顺应性(r=-0.888)及肺血管阻力(r=0.698)显著相关。
- Ea预测无事件生存的AUC为0.724,亚组分析均显示预测价值。
核心结论
- Ea与右心室后负荷指标密切相关,Ea升高是心衰患者不良预后的独立预测因子。
研究设计与样本
- 回顾性队列研究,纳入2013年9月至2022年2月在阜外医院心衰中心行右心导管检查的284例心衰患者。
- Ea计算公式为平均肺动脉压/每搏输出量,按中位值0.555 mmHg/ml分为Ea<0.555组和Ea≥0.555组。
- 主要终点为全因死亡、心脏移植、左心室辅助装置植入和心衰再住院的复合事件。
主要发现
- 中位年龄51岁,男性206例(72.5%),中位随访392(166,811)天。
- Ea≥0.555组NT-proBNP、肺血管阻力更高,心输出量、肺动脉顺应性更低(P均<0.001)。
- Kaplan-Meier显示Ea≥0.555组无事件生存率低于Ea<0.555组(Plog-rank<0.001)。
- 多因素Cox回归显示Ea是主要终点的独立预测因子(HR=1.734,95%CI 1.314~2.289,P<0.001)。
- Ea预测无事件生存的AUC为0.724(P<0.001)。
关键数值与推荐
- Ea中位值0.555 mmHg/ml(1 mmHg=0.133 kPa)作为分组切点。
- Ea与肺动脉顺应性相关r=-0.888(P<0.001),与肺血管阻力相关r=0.698(P<0.001)。
- Ea预测无事件生存的AUC为0.724(P<0.001)。
临床怎么用
- 对于行右心导管检查的心衰患者,可计算Ea以评估右心室后负荷和预后风险。
- Ea≥0.555 mmHg/ml提示不良事件风险增高,可考虑加强随访和干预。
局限性
- 本研究为单中心回顾性队列研究,样本量284例,结论需外推验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the predictive value of pulmonary effective arterial elastance (Ea) in patients with heart failure (HF). Methods: This is a retrospective cohort study, which retrospectively included 284 patients with HF who underwent right heart catheterization at Heart Failure Center in Fuwai Hospital between September 2013 and February 2022. Data regarding baseline clinical characteristics, hemodynamic profiles, and prognosis were collected. Ea was calculated as mean pulmonary arterial pressure/stroke volume. Patients were divided into Ea<0.555 group and Ea≥0.555 group according to the median value of Ea (0.555 mmHg/ml, 1 mmHg=0.133 kPa). The primary outcome was the primary clinical event, set as the first occurrence of a series of composite events, including all-cause death, heart transplantation, left ventricular assist device implantation, and HF rehospitalization. Event-free survival was defined as the absence of primary clinical events. Spearman correlation analysis was used to calculate the correlation coefficient between Ea and parameters reflective of right heart function. The Kaplan-Meier analysis was used to compare the different groups for the estimation of outcomes with the log-rank test. We used Cox proportional-hazards regression models to estimate hazard ratios (HR) for primary clinical event. Subgroup analysis was performed based on the age, gender, New York Heart Association (NYHA) functional class, left ventricular ejection fraction, presence of pulmonary hypertension, and serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) values. We used receiver operating characteristic (ROC) curve to calculate the area under the curve (AUC) of Ea for predicting event-free survival in patients with HF. Results: The median age was 51 years, and 206 (72.5%) patients were male. Ea and pulmonary vascular resistance (PVR) were significantly correlated (r=0.698, P<0.001). The correlation between Ea and pulmonary arterial elastance (PAC) were even more significant (r=-0.888, P<0.001). Compared with Ea<0.555 group, Ea≥0.555 group presented with higher serum NT-proBNP values (4 443 (1 792, 8 554) ng/L vs. 1 721 (480, 4 528)ng/L,P<0.001), higher PVR (3.4 (2.5, 4.7) Wood vs. 1.4 (0.9, 2.2) Wood, P<0.001), lower cardiac output (3.0 (2.3, 3.9) L/min vs. 4.3 (3.8, 4.9) L/min, P<0.001), and lower PAC (1.6 (1.3, 2.0) ml/mmHg vs. 4.0 (3.0, 6.0) ml/mmHg, P<0.001). The median follow-up time was 392 (166, 811) days. The Kaplan-Meier survival curve demonstrated a lower event-free survival rate in the Ea≥0.555 group compared to the Ea<0.555 group (Plog-rank<0.001). After multivariate adjustment, Ea (HR=1.734, P<0.001) remained significantly associated with the primary outcome. Subgroup analysis indicated that Ea was associated with the primary outcome across all subgroups. The AUC was 0.724 (P<0.001) for Ea to predict event-free survival calculated from ROC analysis. Conclusions: Ea is closely related to parameters reflective of right ventricular afterload. Increased Ea is an independent predictor of adverse outcomes in patients with HF. 目的: 评估肺有效动脉弹性(Ea)在心力衰竭(心衰)患者长期预后评估中的潜在价值。 方法: 该研究为回顾性队列研究,纳入2013年9月至2022年2月在阜外医院心衰中心行漂浮导管检查的284例心衰患者。收集患者的基线临床资料、血流动力学数据及预后信息。Ea的计算公式为平均肺动脉压/每搏输出量。根据Ea的中位数值(0.555 mmHg/ml,1 mmHg=0.133 kPa)将患者分为Ea<0.555组和Ea≥0.555组。主要终点为主要临床事件,设定为包括全因死亡、心脏移植、左心室辅助装置植入和因心衰再住院的复合事件。无事件生存定义为未发生主要临床事件。采用Spearman相关性分析Ea与右心功能指标的相关性。采用Kaplan-Meier法进行生存分析,log-rank法比较两组间无事件生存率差异。采用Cox比例风险回归模型分析Ea与主要临床事件的关联,并根据研究对象的年龄、性别、纽约心脏协会(NYHA)心功能分级、左心室射血分数、是否合并肺动脉高压以及N末端B型利钠肽原(NT-proBNP)水平进行亚组分析。采用受试者工作特征(ROC)曲线计算Ea预测心衰患者无事件生存的曲线下面积(AUC)。 结果: 所有患者的中位年龄为51岁,男性206例(72.5%)。Ea与肺动脉顺应性(r=-0.888,P<0.001)和肺血管阻力(r=0.698,P<0.001)显著相关。与Ea<0.555组相比,Ea≥0.555组患者的NT-proBNP水平[4 443(1 792,8 554)ng/L比1 721(480,4 528)ng/L,P<0.001]、肺血管阻力[3.4(2.5,4.7)Wood比1.4(0.9,2.2)Wood,P<0.001]更高,心输出量[3.0(2.3,3.9)L/min比4.3(3.8,4.9)L/min,P<0.001]、肺动脉顺应性[1.6(1.3,2.0)ml/mmHg比4.0(3.0,6.0)ml/mmHg,P<0.001]更低。中位随访时间392(166,811)d,Kaplan-Meier生存曲线显示,Ea≥0.555组的无事件生存率低于Ea<0.555组(Plog-rank<0.001)。多因素Cox回归分析结果显示,Ea是主要终点的独立预测因子(HR=1.734,95%CI 1.314~2.289,P<0.001)。亚组分析表明,Ea对各类心衰人群均存在预测价值(P均<0.05)。Ea预测心衰患者无事件生存的AUC为0.724(P<0.001)。 结论: Ea与右心室后负荷指标密切相关,Ea升高是心衰患者不良预后的独立预测因子。.
引用
- Wu, Huang, Feng, et al. [Prognostic performance of pulmonary effective arterial elastance in patients with heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 38644255. doi:10.3760/cma.j.cn112148-20231120-00449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。